Manufacturer of Controlled Substances; Notice of Registration, 31314-31315 [E9-15446]
Download as PDF
31314
Federal Register / Vol. 74, No. 124 / Tuesday, June 30, 2009 / Notices
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–15443 Filed 6–29–09; 8:45 am]
Springfield, Virginia 22152; and must be
filed no later than August 31, 2009.
Dated: June 22, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–15442 Filed 6–29–09; 8:45 am]
BILLING CODE 4410–09–P
Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–15447 Filed 6–29–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on May 8, 2009,
Chattem Chemicals Inc., 3801 St. Elmo
Avenue, Building 18, Chattanooga,
Tennessee 37409, made application by
renewal to the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Schedule
sroberts on PROD1PC70 with NOTICES6
4–Methoxyamphetamine (7411) ...
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methamphetamine (1105) .............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) .................
Hydrocodone (9193) .....................
Meperidine (9230) .........................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ....................
Noroxymorphone (9668) ...............
Alfentanil (9737) ............................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) .............................
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
VerDate Nov<24>2008
19:55 Jun 29, 2009
Jkt 217001
By Notice dated September 22, 2008,
and published in the Federal Register
on September 29, 2008, (73 FR 56612),
Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066–1742, made application by letter
to the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Gamma Hydroxybutyric
Acid (2010), a basic class of controlled
substance listed in schedule I.
The company plans to produce
sodium oxybate for sale to customers.
One objection was received; however,
the objector is not registered with DEA
as a bulk manufacturer of Gamma
Hydroxybutyric Acid (GHB). DEA has
determined that the objection received
is without merit and does not warrant
denial of the application. DEA has also
determined that the Food and Drug
Administration does not preclude the
sale of GHB to other manufacturers for
the development of generic GHB
products.
DEA has considered the factors in 21
U.S.C. 823(a) and determined that the
registration of Johnson Matthey Inc. to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Johnson Matthey Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 19, 2008, and
published in the Federal Register on
June 27, 2008, (73 FR 36573), Norac
Inc., 405 S. Motor Avenue, P.O. Box
577, Azusa, California 91702–3232,
made application by letter to the Drug
Enforcement Administration (DEA) for
registration as a bulk manufacturer of
Gamma Hydroxybutyric Acid (2010), a
basic class of controlled substance listed
in schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for sale to its customers.
One objection was received; however,
the objector is not registered with DEA
as a bulk manufacturer of Gamma
Hydroxybutyric Acid (GHB). DEA has
determined that the objection received
is without merit and does not warrant
denial of the application. DEA has also
determined that the Food & Drug
Administration does not preclude the
sale of GHB to other manufacturers for
the development of generic GHB
products.
DEA has considered the factors in 21
U.S.C. 823(a) and determined that the
registration of Norac Inc. to manufacture
the listed basic class of controlled
substance is consistent with the public
interest at this time. DEA has
investigated Norac Inc. to ensure that
the company’s registration is consistent
with the public interest. The
investigation included the inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
E:\FR\FM\30JNN1.SGM
30JNN1
Federal Register / Vol. 74, No. 124 / Tuesday, June 30, 2009 / Notices
Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–15446 Filed 6–29–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Submission for OMB Review:
Comment Request
sroberts on PROD1PC70 with NOTICES6
June 25, 2009.
The Department of Labor (DOL)
hereby announces the submission of the
following public information collection
requests (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(Pub. L. 104–13, 44 U.S.C. chapter 35).
A copy of each ICR, with applicable
supporting documentation; including
among other things a description of the
likely respondents, proposed frequency
of response, and estimated total burden
may be obtained from the RegInfo.gov
Web site at https://www.reginfo.gov/
public/do/PRAMain or by contacting
Darrin King on 202–693–4129 (this is
not a toll-free number)/e-mail:
DOL_PRA_PUBLIC@dol.gov.
Interested parties are encouraged to
send comments to the Office of
Information and Regulatory Affairs,
Attn: OMB Desk Officer for the
Department of Labor—Bureau of Labor
Statistics (BLS), Office of Management
and Budget, Room 10235, Washington,
DC 20503, Telephone: 202–395–7316/
Fax: 202–395–5806 (these are not tollfree numbers), e-mail:
OIRA_submission@omb.eop.gov within
30 days from the date of this publication
in the Federal Register. In order to
ensure the appropriate consideration,
comments should reference the OMB
Control Number (see below).
The OMB is particularly interested in
comments which:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
VerDate Nov<24>2008
19:55 Jun 29, 2009
Jkt 217001
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Agency: Bureau of Labor Statistics.
Type of Review: Extension without
change of a currently approved
collection.
Title of Collection: General Inquiries
to State Agency Contacts.
OMB Control Number: 1220–0168.
Affected Public: State, Local, and
Tribal Governments.
Total Estimated Number of
Respondents: 54.
Total Estimated Annual Burden
Hours: 15,927.
Total Estimated Annual Costs Burden:
$0.
Description: BLS awards funds to
State Agencies in order to assist them in
operating Labor Market Information
and/or Occupational Safety and Health
Statistics Federal/State cooperative
statistical programs. To ensure a timely
flow of data and to be able to evaluate
and improve the programs it is
necessary to conduct ongoing
communications between BLS and the
State partners dealing with, for example,
deliverables, program enhancements,
and administrative issues. For
additional information, see related
notice published at Vol. 74 FR 12386 on
March 24, 2009.
Agency: Bureau of Labor Statistics.
Type of Review: Revision of a
currently approved collection.
Title of Collection: American Time
Use Survey (ATUS).
OMB Control Number: 1220–0175.
Affected Public: Individuals or
households.
Total Estimated Number of
Respondents: 13,240.
Total Estimated Annual Burden
Hours: 4,358.
Total Estimated Annual Costs Burden:
$0.
Description: The ATUS is the Nation’s
first federally administered, continuous
survey on time use in the United States.
It measures, for example, time spent
with children, working, sleeping, or
doing leisure activities. In the United
States, several existing Federal surveys
collect income and wage data for
individuals and families, and analysts
often use such measures of material
prosperity as proxies for quality of life.
Time-use data substantially augment
these quality-of-life measures. The data
also can be used in conjunction with
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
31315
wage data to evaluate the contribution
of non-market work to national
economies. This enables comparisons of
production between nations that have
different mixes of market and nonmarket activities. The ATUS develops
nationally representative estimates of
how people spend their time.
Respondents also report who was with
them during activities, where they were,
how long each activity lasted, and if
they were paid. All of this information
has numerous practical applications for
sociologists, economists, educators,
government policymakers,
businesspersons, health researchers, and
others.
The ATUS data are collected on an
ongoing, monthly basis, allowing
analysts to identify changes in how
people spend their time. The survey
sample is drawn from households
completing their final month of
interviews for the Current Population
Survey (CPS). Households are selected
to ensure a representative demographic
sample, and one individual from each
household is selected to take part in one
Computer Assisted Telephone
Interview. The interview asks
respondents to report all of their
activities for one pre-assigned 24-hour
day, the day prior to the interview. A
short series of summary questions and
CPS updates follows the core time diary
collection.
For additional information, see
related notice published at Vol. 74 FR
14160 on March 30, 2009.
Darrin A. King,
Departmental Clearance Officer.
[FR Doc. E9–15433 Filed 6–29–09; 8:45 am]
BILLING CODE 4510–24–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice 09–061]
NASA Advisory Council; Meeting
AGENCY: National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
SUMMARY: In accordance with the
Federal Advisory Committee Act, Public
Law 92–463, as amended, the National
Aeronautics and Space Administration
announces a meeting of the NASA
Advisory Council’s Aeronautics, Audit
and Finance, Exploration, Human
Capital, Science, and Space Operations
Committees. The agendas for the
committees include updates from the
prior NAC meeting held at NASA
Headquarters in April 2009 as well as
discussion of potential
E:\FR\FM\30JNN1.SGM
30JNN1
Agencies
[Federal Register Volume 74, Number 124 (Tuesday, June 30, 2009)]
[Notices]
[Pages 31314-31315]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15446]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 19, 2008, and published in the Federal
Register on June 27, 2008, (73 FR 36573), Norac Inc., 405 S. Motor
Avenue, P.O. Box 577, Azusa, California 91702-3232, made application by
letter to the Drug Enforcement Administration (DEA) for registration as
a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class
of controlled substance listed in schedule I.
The company plans to manufacture the listed controlled substance in
bulk for sale to its customers.
One objection was received; however, the objector is not registered
with DEA as a bulk manufacturer of Gamma Hydroxybutyric Acid (GHB). DEA
has determined that the objection received is without merit and does
not warrant denial of the application. DEA has also determined that the
Food & Drug Administration does not preclude the sale of GHB to other
manufacturers for the development of generic GHB products.
DEA has considered the factors in 21 U.S.C. 823(a) and determined
that the registration of Norac Inc. to manufacture the listed basic
class of controlled substance is consistent with the public interest at
this time. DEA has investigated Norac Inc. to ensure that the company's
registration is consistent with the public interest. The investigation
included the inspection and testing of the company's physical security
systems, verification of the company's compliance with State and local
laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 823 and in accordance with 21 CFR
1301.33, the above named company is granted registration as a bulk
manufacturer of the basic class of controlled substance listed.
[[Page 31315]]
Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-15446 Filed 6-29-09; 8:45 am]
BILLING CODE 4410-09-P